Literature DB >> 15580588

Combined radiation therapy and dendritic cell vaccine for treating solid tumors with liver micro-metastasis.

Zhuang Chen1, Dajing Xia, Xuguang Bi, Anurag Saxena, Narinder Sidhu, Ali El-Gayed, Jim Xiang.   

Abstract

BACKGROUND: Tumor metastasis and relapse are major obstacles in combating human malignant diseases. Neither radiotherapy alone nor injection of dendritic cells (DCs) can successfully overcome this problem. Radiation induces tumor cell apoptosis and necrosis, resulting in the release of tumor antigen and danger signals, which are favorable for DC capturing antigens and maturation. Hence, the strategy of combined irradiation and DC vaccine may be a novel approach for treating human malignancies and early metastasis.
METHODS: To develop an effective combined therapeutic approach, we established a novel concomitant local tumor and liver metastases model through subcutaneous (s.c.) and intravenous (i.v.) injection. We selected the optimal time for DC injection after irradiation and investigated the antitumor effect of combining irradiation with DC intratumoral injection and the related mechanism.
RESULTS: Combined treatment with radiotherapy and DC vaccine could induce a potent antitumor immune response, resulting in a significant decrease in the rate of local tumor relapse and the numbers of liver metastases. The related mechanisms for this strong antitumor immunity of this combined therapy might be associated with the production of apoptotic and necrotic tumor antigens and heat shock proteins after irradiation, phagocytosis, migration and maturation of DCs, and induction of more efficient tumor-specific cytotoxic T lymphocyte activity through a cross-presentation pathway.
CONCLUSIONS: Co-administration of local irradiation and intratumoral DC injection may be a promising strategy for treating radiosensitive tumors and eliminating metastasis in the clinic. Copyright (c) 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580588     DOI: 10.1002/jgm.692

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  13 in total

Review 1.  Tumor cell lysates as immunogenic sources for cancer vaccine design.

Authors:  Fermín E González; Alejandra Gleisner; Felipe Falcón-Beas; Fabiola Osorio; Mercedes N López; Flavio Salazar-Onfray
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.

Authors:  Steven E Finkelstein; Cristina Iclozan; Marilyn M Bui; Matthew J Cotter; Rupal Ramakrishnan; Jamil Ahmed; David R Noyes; David Cheong; Ricardo J Gonzalez; Randy V Heysek; Claudia Berman; Brianna C Lenox; William Janssen; Jonathan S Zager; Vernon K Sondak; G Douglas Letson; Scott J Antonia; Dmitry I Gabrilovich
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-03-11       Impact factor: 7.038

3.  Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model.

Authors:  Seagal Teitz-Tennenbaum; Qiao Li; Mary A Davis; Alfred E Chang
Journal:  Clin Immunol       Date:  2008-10-08       Impact factor: 3.969

4.  Local irradiation of murine melanoma affects the development of tumour-specific immunity.

Authors:  Yu-Pei Liao; Chun-Chieh Wang; Dörthe Schaue; Keisuke S Iwamoto; William H McBride
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

5.  Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.

Authors:  Seagal Teitz-Tennenbaum; Qiao Li; Ryuji Okuyama; Mary A Davis; Rong Sun; Joel Whitfield; Randall N Knibbs; Lloyd M Stoolman; Alfred E Chang
Journal:  J Immunother       Date:  2008-05       Impact factor: 4.456

6.  Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation.

Authors:  Ken Ando; Hidetoshi Fujita; Akihiro Hosoi; Liqiu Ma; Masaru Wakatsuki; Ken-Ichiro Seino; Kazuhiro Kakimi; Takashi Imai; Takashi Shimokawa; Takashi Nakano
Journal:  J Radiat Res       Date:  2017-07-01       Impact factor: 2.724

Review 7.  Immune cell recruitment and cell-based system for cancer therapy.

Authors:  Jian-Qing Gao; Naoki Okada; Tadanori Mayumi; Shinsaku Nakagawa
Journal:  Pharm Res       Date:  2007-09-22       Impact factor: 4.200

8.  Therapeutic response in patients with advanced malignancies treated with combined dendritic cell-activated T cell based immunotherapy and intensity-modulated radiotherapy.

Authors:  Kenichiro Hasumi; Yukimasa Aoki; Ryuko Watanabe; Kim G Hankey; Dean L Mann
Journal:  Cancers (Basel)       Date:  2011-04-28       Impact factor: 6.639

9.  Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy.

Authors:  Kenichiro Hasumi; Yukimasa Aoki; Ryuko Wantanabe; Dean L Mann
Journal:  Oncoimmunology       Date:  2013-10-17       Impact factor: 8.110

10.  Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma model.

Authors:  Joanne Yh Lim; Dirk G Brockstedt; Edith M Lord; Scott A Gerber
Journal:  Oncoimmunology       Date:  2014-06-03       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.